Why should we expand beyond the US market? What are the potential pathways? How does the company decide between them?

Attendees to this webinar will hear from a panel of seasoned biopharma executives who have successfully grappled with these same questions. In particular, attendees will:

Learn about the major pathways to value companies have taken over the past few years (i.e., does “going it alone” generate more value than partnering?).
Explore a framework for assessing the options and making critical strategic decisions on your own journey.
Discuss case studies from companies that have taken different pathways to value.